Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph‐positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 studyMichael B. Lilly, Giovanni Martinelli, Aude Charbonnier et al.|American Journal of Hematology|2009Cited by 98